Evidence map›Paper›PMID 28781951›Full record

ArticleFEBS open bio2017

IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells.

Yudong Fu, Zhongcheng Zhou, Hua Wang, Peng Gong, Renpeng Guo, Jinmiao Wang, Xinyi Lu, Feng Qi, Lin Liu

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yudong FuState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Zhongcheng ZhouState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Hua WangState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Peng GongState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Renpeng GuoState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Jinmiao WangDepartment of General Surgery Tianjin Medical University General Hospital China.
Xinyi LuState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Feng QiDepartment of General Surgery Tianjin Medical University General Hospital China.
Lin LiuState Key Laboratory of Medicinal Chemical Biology College of Life Sciences Nankai University Tianjin China.
Nankai University · CNTianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon-induced transmembrane protein 1 (IFITM1), a member of the IFITM protein family, is a component of a multimeric complex involved in the transduction of antiproliferation and cell adhesion signals. IFITM1 is thought to play a role in antiproliferation and immune surveillance, and has been shown to restrict infection by numerous viruses. It is highly expressed in human embryonic stem cells (hESCs) but its role in hESCs remains to be elucidated. In this study, knockout of

Indexed as

H3K9me3human embryonic stem cellIFITM1

Identifiers

PMID28781951
PMCPMC5537067
OpenAlexW2617882125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.